The Effect of the Angiotensin-Converting Enzyme Inhibitor Perindopril on the Lipid Status of Rattus Norvegicus (Berkenhout 1769)

被引:0
|
作者
Haskovic, Elma [1 ]
Dolicanin, Azra [2 ,3 ]
Haskovic, Edhem [2 ,3 ]
Herenda, Safija
Lepara, Orhan [4 ]
机构
[1] Univ Sarajevo, Fac Pharm, Zmaja Od Bosne 8, Sarajevo 71000, Bosnia & Herceg
[2] Univ Sarajevo, Fac Sci, Dept Biol, Zmaja Od Bosne 33-35, Sarajevo 71000, Bosnia & Herceg
[3] Univ Sarajevo, Fac Sci, Dept Chem, Zmaja Od Bosne 33-35, Sarajevo 71000, Bosnia & Herceg
[4] Univ Sarajevo, Fac Med, Cekalusa 90, Sarajevo 71000, Bosnia & Herceg
来源
MEDICON 2023 AND CMBEBIH 2023, VOL 1 | 2024年 / 93卷
关键词
Perindopril; In vivo studies; Lipid profile; CHOLESTEROL RATIO; HDL-CHOLESTEROL; DRUGS;
D O I
10.1007/978-3-031-49062-0_39
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
Angiotensin-converting enzyme (ACE) inhibitors are an important group of drugs that are widely used in the treatment of hypertension and congestive heart failure. Perindopril is an ester-inactive form of the angiotensin-converting inhibitor perindoprilat. Compared to other an- giotensin-converting enzyme inhibitors, perindopril has a higher affinity and lipophilicity. The aim of this work was to investigate the effect of the angiotensin-converting enzyme inhibitor, perindopril, on the lipid status of Rattus norvegicus (Berkenhout 1769), Wistar strain. After four days of subcutaneous application of perindopril in individuals of the species Rattus norvegicus, changes in the concentration of the investigated parameters were recorded. The individuals were divided into two experimental groups of 10 individuals each. Individuals of the first experimental group were administered an aqueous solution of perindopril at a concentration of 0.8 mg/kg, while individuals of the second experimental group were administered perindopril at a concentration of 1.6 mg/kg of body weight. By mutual comparison of the results obtained between the two experimental groups, it can be concluded that there was a change in the concentration of all tested parameters, and there is also a difference in the values of the tested parameters of the lipid profile in both tested groups compared to reference literature data (total cholesterol (UH) 2.95 mmol/l, triglycerides (Tg) 0.86 mmol/l, HDL-cholesterol 1.27 mmol/l, LDL-cholesterol 1.28 mmol/l and VLDL cholesterol 0.39 mmol/l, with the difference being greater in the group with a higher applied dose.
引用
收藏
页码:353 / 367
页数:15
相关论文
共 50 条
  • [1] Effect of the angiotensin-converting enzyme inhibitor perindopril on haemostasis in essential hypertension
    Remková, A
    Kratochvíl'ová, H
    BLOOD COAGULATION & FIBRINOLYSIS, 2000, 11 (07) : 641 - 644
  • [2] Neuroprotective effect of the angiotensin-converting enzyme inhibitor perindopril in MPTP-treated mice
    Kurosaki, R
    Muramatsu, Y
    Imai, Y
    Kato, H
    Araki, T
    NEUROLOGICAL RESEARCH, 2004, 26 (06) : 644 - 657
  • [3] Effect of angiotensin-converting enzyme inhibitor perindopril on interneurons in MPTP-treated mice
    Kurosaki, R
    Muramatsu, Y
    Kato, H
    Watanabe, Y
    Imai, Y
    Itoyama, Y
    Araki, T
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2005, 15 (01) : 57 - 67
  • [4] Principles of choice of an angiotensin-converting enzyme inhibitor: Specific features of perindopril
    Morozova, T. E.
    Gontarenko, S. V.
    Kuzmina, E. R.
    TERAPEVTICHESKII ARKHIV, 2014, 86 (09) : 115 - +
  • [5] Efficacy of perindopril, inhibitor of angiotensin-converting enzyme, in congestive heart failure
    Tereschenko, SN
    Drozdov, VN
    Demidova, IV
    Levchuk, NN
    Moiseev, VS
    TERAPEVTICHESKII ARKHIV, 1997, 69 (07) : 53 - 56
  • [6] Angiotensin-converting enzyme inhibition by perindopril in cardiovascular disease
    Simoons, Maarten L.
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2009, 11 (0E) : E4 - E8
  • [7] INTERSPECIES COMPARISON OF THE METABOLIC PATHWAYS OF PERINDOPRIL, A NEW ANGIOTENSIN-CONVERTING ENZYME (ACE) INHIBITOR
    GRISLAIN, L
    MOCQUARD, MT
    DABE, JF
    BERTRAND, M
    LUIJTEN, W
    MARCHAND, B
    RESPLANDY, G
    DEVISSAGUET, M
    XENOBIOTICA, 1990, 20 (08) : 787 - 800
  • [8] 'Effects of the angiotensin-converting enzyme inhibitor perindopril on endothelial and platelet function in essential hypertension'
    Jagroop, IA
    Papadakis, JA
    Mikhailidis, DP
    PLATELETS, 1998, 9 (06) : 395 - 396
  • [9] ANGIOTENSIN-CONVERTING ENZYME INHIBITOR ANGIOEDEMA
    Bolton, Michaelina R.
    Dooley-Hash, Suzanne L.
    JOURNAL OF EMERGENCY MEDICINE, 2012, 43 (04): : E261 - E262
  • [10] Angiotensin-Converting Enzyme Inhibitor Angioedema
    Bankston, Josh
    House, David Thomas
    ADVANCED EMERGENCY NURSING JOURNAL, 2020, 42 (02) : 103 - 107